STABLESCRIPT Trademark

Trademark Overview


On Tuesday, September 22, 2020, a trademark application was filed for STABLESCRIPT with the United States Patent and Trademark Office. The USPTO has given the STABLESCRIPT trademark a serial number of 90200034. The federal status of this trademark filing is REGISTERED as of Tuesday, February 15, 2022. This trademark is owned by Qiagen Beverly, LLC. The STABLESCRIPT trademark is filed in the Chemical Products and Pharmaceutical Products categories with the following description:

Diagnostic preparations for medical and veterinary purposes, namely, diagnostics preparations for the marking, separating, isolating, amplifying, cloning, sequencing and analysis of biopolymers, namely, nucleic acids; diagnostic reagents, enzymes and buffer solutions for nucleic acid amplification and cloning for medical or veterinary purposes; chemical, biochemical and biotechnological diagnostic preparations for medical and veterinary purposes, namely, reagents, enzymes and buffer solutions for the marking, separating, isolating, amplifying, cloning, sequencing and analysis of biopolymers, namely, nucleic acids; diagnostic kits comprised of preparations for medical and veterinary diagnostic purposes, namely, preparations for marking, separating, isolating, amplifying, cloning, sequencing and analysis of biopolymers, namely, nucleic acids; diagnostic kits containing reagents, enzymes and buffer solutions for nucleic acid amplification and cloning for medical or veterinary purposes

Chemical, biochemical and biotechnological diagnostic preparations for scientific purposes, namely, buffer solutions for the marking, separating, isolating, amplifying, cloning, sequencing and analysis of biopolymers, in particular nucleic acids, in particular reagents, enzymes and buffer solutions for nucleic acid amplification and cloning; chemical test kits for laboratory or research use featuring chemicals for the marking, separating, isolating, amplifying, cloning, sequencing and analysis of biopolymers, in particular nucleic acids, in particular comprising reagents, enzymes and buffer solutions for nucleic acid amplification and cloning
stablescript

General Information


Serial Number90200034
Word MarkSTABLESCRIPT
Filing DateTuesday, September 22, 2020
Status700 - REGISTERED
Status DateTuesday, February 15, 2022
Registration Number6647692
Registration DateTuesday, February 15, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 10, 2021

Trademark Statements


Goods and ServicesDiagnostic preparations for medical and veterinary purposes, namely, diagnostics preparations for the marking, separating, isolating, amplifying, cloning, sequencing and analysis of biopolymers, namely, nucleic acids; diagnostic reagents, enzymes and buffer solutions for nucleic acid amplification and cloning for medical or veterinary purposes; chemical, biochemical and biotechnological diagnostic preparations for medical and veterinary purposes, namely, reagents, enzymes and buffer solutions for the marking, separating, isolating, amplifying, cloning, sequencing and analysis of biopolymers, namely, nucleic acids; diagnostic kits comprised of preparations for medical and veterinary diagnostic purposes, namely, preparations for marking, separating, isolating, amplifying, cloning, sequencing and analysis of biopolymers, namely, nucleic acids; diagnostic kits containing reagents, enzymes and buffer solutions for nucleic acid amplification and cloning for medical or veterinary purposes
Pseudo MarkSTABLE SCRIPT
Goods and ServicesChemical, biochemical and biotechnological diagnostic preparations for scientific purposes, namely, buffer solutions for the marking, separating, isolating, amplifying, cloning, sequencing and analysis of biopolymers, in particular nucleic acids, in particular reagents, enzymes and buffer solutions for nucleic acid amplification and cloning; chemical test kits for laboratory or research use featuring chemicals for the marking, separating, isolating, amplifying, cloning, sequencing and analysis of biopolymers, in particular nucleic acids, in particular comprising reagents, enzymes and buffer solutions for nucleic acid amplification and cloning

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateFriday, October 30, 2020
Primary Code001
First Use Anywhere DateTuesday, August 31, 2021
First Use In Commerce DateTuesday, August 31, 2021

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, October 30, 2020
Primary Code005
First Use Anywhere DateTuesday, August 31, 2021
First Use In Commerce DateTuesday, August 31, 2021

Trademark Owner History


Party NameQiagen Beverly, LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressBeverly, MA 01915

Party NameQiagen Beverly, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressBeverly, MA 01915

Party NameQiagen Beverly, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressBeverly, MA 01915

Trademark Events


Event DateEvent Description
Tuesday, February 15, 2022REGISTERED-PRINCIPAL REGISTER
Tuesday, January 11, 2022NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, January 10, 2022ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, December 20, 2021STATEMENT OF USE PROCESSING COMPLETE
Tuesday, November 23, 2021USE AMENDMENT FILED
Friday, December 17, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, November 23, 2021TEAS STATEMENT OF USE RECEIVED
Tuesday, October 5, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 10, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 10, 2021PUBLISHED FOR OPPOSITION
Wednesday, July 21, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, July 1, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, July 1, 2021EXAMINER'S AMENDMENT ENTERED
Thursday, July 1, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, July 1, 2021EXAMINERS AMENDMENT E-MAILED
Thursday, July 1, 2021EXAMINERS AMENDMENT -WRITTEN
Thursday, July 1, 2021NOTIFICATION OF FINAL REFUSAL EMAILED
Thursday, July 1, 2021FINAL REFUSAL E-MAILED
Thursday, July 1, 2021FINAL REFUSAL WRITTEN
Tuesday, June 8, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, June 8, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, June 7, 2021ASSIGNED TO LIE
Thursday, March 11, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, February 15, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, February 15, 2021NON-FINAL ACTION E-MAILED
Monday, February 15, 2021NON-FINAL ACTION WRITTEN
Monday, February 8, 2021ASSIGNED TO EXAMINER
Friday, October 30, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, September 25, 2020NEW APPLICATION ENTERED IN TRAM